Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 09, 2024

BUY
$209.01 - $232.56 $74,407 - $82,791
356 Added 3.03%
12,097 $2.64 Million
Q4 2023

Feb 13, 2024

SELL
$197.69 - $227.29 $195,317 - $224,562
-988 Reduced 7.76%
11,741 $2.67 Million
Q3 2023

Oct 30, 2023

SELL
$201.05 - $221.7 $64,537 - $71,165
-321 Reduced 2.46%
12,729 $2.56 Million
Q2 2023

Aug 14, 2023

SELL
$211.93 - $241.33 $29,246 - $33,303
-138 Reduced 1.05%
13,050 $3.15 Million
Q1 2023

May 12, 2023

SELL
$213.32 - $257.83 $4,266 - $5,156
-20 Reduced 0.15%
13,188 $3.03 Million
Q4 2022

Feb 13, 2023

BUY
$203.72 - $248.97 $144,030 - $176,021
707 Added 5.66%
13,208 $3.11 Million
Q3 2022

Nov 03, 2022

BUY
$204.81 - $262.19 $136,608 - $174,880
667 Added 5.64%
12,501 $2.56 Million
Q2 2022

Aug 09, 2022

SELL
$213.86 - $277.87 $886,235 - $1.15 Million
-4,144 Reduced 25.94%
11,834 $2.77 Million
Q1 2022

May 06, 2022

SELL
$259.82 - $298.18 $1.55 Million - $1.78 Million
-5,964 Reduced 27.18%
15,978 $4.21 Million
Q4 2021

Feb 08, 2022

BUY
$271.6 - $314.21 $92,887 - $107,459
342 Added 1.58%
21,942 $6.89 Million
Q3 2021

Nov 09, 2021

BUY
$274.82 - $308.34 $2.74 Million - $3.08 Million
9,982 Added 85.92%
21,600 $6.08 Million
Q2 2021

Aug 16, 2021

BUY
$251.87 - $278.14 $45,084 - $49,787
179 Added 1.56%
11,618 $3.21 Million
Q1 2021

May 14, 2021

SELL
$204.88 - $255.03 $3,278 - $4,080
-16 Reduced 0.14%
11,439 $2.92 Million
Q4 2020

Feb 03, 2021

SELL
$186.91 - $214.42 $14,018 - $16,081
-75 Reduced 0.65%
11,455 $2.33 Million
Q3 2020

Nov 05, 2020

BUY
$167.03 - $201.3 $16,034 - $19,324
96 Added 0.84%
11,530 $2.17 Million
Q2 2020

Jul 28, 2020

SELL
$113.31 - $182.44 $33,199 - $53,454
-293 Reduced 2.5%
11,434 $1.9 Million
Q1 2020

Apr 30, 2020

SELL
$104.32 - $195.28 $133,633 - $250,153
-1,281 Reduced 9.85%
11,727 $1.48 Million
Q4 2019

Feb 14, 2020

SELL
$163.48 - $173.61 $23,868 - $25,347
-146 Reduced 1.11%
13,008 $2.2 Million
Q3 2019

Oct 30, 2019

SELL
$159.77 - $178.1 $100,974 - $112,559
-632 Reduced 4.58%
13,154 $2.21 Million
Q2 2019

Aug 05, 2019

SELL
$144.16 - $172.9 $132,483 - $158,895
-919 Reduced 6.25%
13,786 $2.38 Million
Q1 2019

May 06, 2019

BUY
$123.7 - $156.3 $163,036 - $206,003
1,318 Added 9.85%
14,705 $2.25 Million
Q4 2018

Feb 12, 2019

BUY
$120.82 - $174.09 $68,746 - $99,057
569 Added 4.44%
13,387 $1.69 Million
Q3 2018

Nov 02, 2018

SELL
$167.67 - $188.27 $28,839 - $32,382
-172 Reduced 1.32%
12,818 $2.23 Million
Q2 2018

Aug 09, 2018

BUY
$160.33 - $189.41 $85,616 - $101,144
534 Added 4.29%
12,990 $2.33 Million
Q1 2018

Apr 30, 2018

SELL
$161.53 - $178.11 $99,825 - $110,071
-618 Reduced 4.73%
12,456 $2.02 Million
Q4 2017

Feb 02, 2018

SELL
$147.99 - $163.95 $96,489 - $106,895
-652 Reduced 4.75%
13,074 $2.09 Million
Q3 2017

Nov 06, 2017

BUY
$149.47 - $160.56 $2.05 Million - $2.2 Million
13,726
13,726 $2.07 Million

Others Institutions Holding LH

About LABORATORY CORP OF AMERICA HOLDINGS


  • Ticker LH
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 89,600,000
  • Market Cap $21.7B
  • Description
  • Laboratory Corporation of America Holdings operates as a global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). It offers various tests,...
More about LH
Track This Portfolio

Track Cibc Asset Management Inc Portfolio

Follow Cibc Asset Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cibc Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Cibc Asset Management Inc with notifications on news.